IP Library Granted Patent US 8,530,192
Granted Patent B2
US 8,530,192 · App. 11/815,880 · Granted Sep 10, 2013

Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate

Inventor: Ida Molgaard Knudsen (Værløse, DK)
Assignee: Novo Nordisk Healthcare AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,530,192
App. No.
11/815,880
Granted
Sep 10, 2013
Kind
B2
Abstract

The invention concerns a method for large-scale production of a polypeptide in eukaryote cells contained in a serum-free culture liquid, said method comprising (i) a propagation phase for said cells, where the cells are propagated in a first cell culture liquid, and (ii) a production phase for said cells, where the cells are present in a second cell culture medium liquid, wherein each of the cell culture liquids comprise a plant protein hydrolysate, and wherein the ratio between the concentration of the plant protein hydrolysate (C 1 ) in the first cell culture liquid and the concentration of the plant protein hydrolysate (C 2 ) in the second cell culture liquid is at least 1.5:1 (C 1 :C 2 ).

Claims (53)

1. A method for large-scale production of a polypeptide in eukaryote cells contained in a serum-free culture liquid, said method comprising

(i) a propagation phase for said cells, where the cells are propagated in a first cell culture liquid, and

(ii) a production phase for said cells, where the cells are present in a second cell culture liquid,

wherein each of the cell culture liquids comprise a plant protein hydrolysate, and wherein the ratio between the concentration of the plant protein hydrolysate (C 1 ) in the first cell culture liquid and the concentration of the plant protein hydrolysate (C 2 ) in the second cell culture liquid is at least 1.5:1 (C 1 :C 2 ).

2. The method according to claim 1 , wherein the ratio C 1 :C 2 is in the range of 2:1 to 10:1.

3. The method according to claim 2 , wherein the concentration C 2 is in the range of 0.2-3.5 g/L.

4. The method according to claim 3 , wherein the concentration C 1 is in the range of 4.0-10.0 g/L.

5. The method according to claim 4 , wherein the plant protein hydrolysate is soy protein hydrolysate.

6. The method according to claim 5 , wherein the polypeptide is a Factor VII polypeptide.

7. A method for large-scale production of a Factor VII polypeptide in eukaryote cells contained in a serum-free culture liquid, said method comprising

(i) a propagation phase for said cells, where the cells are propagated in a first cell culture liquid, and

(ii) a production phase for said cells, where the cells are present in a second cell culture liquid,

wherein the first cell culture liquid comprises a soy protein hydrolysate in a concentration of 4.0-10.0 g/L, the second cell culture liquid comprises a soy protein hydrolysate in a concentration of 0.2-3.5 g/L, and wherein the ratio between the concentration of the soy protein hydrolysate (C 1 ) in the first cell culture liquid and the concentration of the soy protein hydrolysate (C 2 ) in the second cell culture liquid is at least 1.5:1 (C 1 :C 2 ).

8. A method for large-scale production of a Factor VII polypeptide in eukaryote cells contained in a serum-free culture liquid, said method comprising

(i) a propagation phase for said cells, where the cells are propagated in a first cell culture liquid, and

(ii) a production phase for said cells, where the cells are present in a second cell culture liquid,

wherein each of the cell culture liquids comprise a plant protein hydrolysate, and wherein the concentration of the plant protein hydrolysate (C 2 ) in the second cell culture liquid is in the range of 0.7-3.0 g/L.

9. The method according to claim 8 , wherein the concentration C 2 is in the range of 0.9-2.5 g/L.

10. The method according to claim 9 , wherein each of the cell culture liquids comprise a plant protein hydrolysate, and wherein the ratio between the concentration of the plant protein hydrolysate (C 1 ) in the first cell culture liquid and the concentration of the plant protein hydrolysate (C 2 ) in the second cell culture liquid is at least 1.5:1.

11. The method according to claim 10 , wherein the concentration C 1 is in the range of 4.0-10.0 g/L.

12. The method according to claim 1 , wherein the concentration of the plant protein hydrolysate observed against time of fermentation has the following profile:

high concentration in the propagation phase (C 1 );

low concentration in the production phase—low level A (C 2A );

low concentration in the production phase—low level B (C 2B );

low concentration in the production phase—low level A (C 2A );

low concentration in the production phase—low level B (C 2B );

where C 1 >>C 2B >C 2A and the concentrations C 2A and C 2B are within the concentration ranges specified for C 2 , and wherein a first switch from low level A (C 2A ) to low level B (C 2B ) is conducted when a decrease in the cell number is observed and a subsequent switch from low level B (C 2B ) to low level A (C 2A ) is conducted when the cell number has been restored to a level approximately corresponding to the level before the decrease.

13. The method according to claim 6 , wherein the concentration of the plant protein hydrolysate observed against time of fermentation has the following profile:

high concentration in the propagation phase (C 1 );

low concentration in the production phase—low level A (C 2A );

low concentration in the production phase—low level B (C 2B );

low concentration in the production phase—low level A (C 2A );

low concentration in the production phase—low level B (C 2B );

where C 1 >>C 2B >C 2A and the concentrations C 2A and C 2B are within the concentration ranges specified for C 2 , and wherein a first switch from low level A (C 2A ) to low level B (C 2B ) is conducted when a decrease in the cell number is observed and a subsequent switch from low level B (C 2B ) to low level A (C 2A ) is conducted when the cell number has been restored to a level approximately corresponding to the level before the decrease.

14. The method according to claim 7 , wherein the concentration of the plant protein hydrolysate observed against time of fermentation has the following profile:

high concentration in the propagation phase (C 1 );

low concentration in the production phase—low level A (C 2A );

low concentration in the production phase—low level B (C 2B );

low concentration in the production phase—low level A (C 2A );

low concentration in the production phase—low level B (C 2B );

where C 1 >>C 2B >C 2A and the concentrations C 2A and C 2B are within the concentration ranges specified for C 2 , and wherein a first switch from low level A (C 2A ) to low level B (C 2B ) is conducted when a decrease in the cell number is observed and a subsequent switch from low level B (C 2B ) to low level A (C 2A ) is conducted when the cell number has been restored to a level approximately corresponding to the level before the decrease.

15. The method according to claim 8 , wherein the concentration of the plant protein hydrolysate observed against time of fermentation has the following profile:

high concentration in the propagation phase (C 1 );

low concentration in the production phase—low level A (C 2A );

low concentration in the production phase—low level B (C 2B );

low concentration in the production phase—low level A (C 2A );

low concentration in the production phase—low level B (C 2B );

where C 1 >>C 2B >C 2A and the concentrations C 2A and C 2B are within the concentration ranges specified for C 2 , and wherein a first switch from low level A (C 2A ) to low level B (C 2B ) is conducted when a decrease in the cell number is observed and a subsequent switch from low level B (C 2B ) to low level A (C 2A ) is conducted when the cell number has been restored to a level approximately corresponding to the level before the decrease.

16. The method according to claim 1 , wherein the concentration C 2 is in the range of 0.2-3.5 g/L.

17. The method according to claim 1 , wherein the concentration C 1 is in the range of 4.0-10.0 g/L.

18. The method according to claim 1 , wherein the plant protein hydrolysate is soy protein hydrolysate.

19. The method according to claim 1 , wherein the polypeptide is a Factor VII polypeptide.

20. The method according to claim 8 , wherein each of the cell culture liquids comprise a plant protein hydrolysate, and wherein the ratio between the concentration of the plant protein hydrolysate (C 1 ) in the first cell culture liquid and the concentration of the plant protein hydrolysate (C 2 ) in the second cell culture liquid is at least 1.5:1.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 19, 2013
From: NOVO NORDISK HEALTHCARE A/G
To: NOVO NORDISK HEALTHCARE AG
Reel/Frame 030653/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2008
From: KNUDSEN, IDA MOLGAARD
To: NOVO NORDISK HEALTHCARE A/G
Reel/Frame 020341/0583 →
Priority Claims (1)
DK 2005 00204 · Feb 11, 2005 · national
Continuity (2)
Provisional Application 60652988 · Feb 15, 2005
Related Publication 20080254514A1 · Oct 16, 2008